mifepristone has been researched along with Pituitary Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, J; Churko, J; Eschbacher, J; Greenstein, AE; Little, AS; Livolsi, A; Mallick, S; Moraitis, AG; Pond, KW; Thorne, CA; Yuen, KCJ; Zavros, Y | 1 |
| Fleseriu, M; Petersenn, S | 1 |
| Buchfelder, M; Findling, JW; Fleseriu, M; Gross, C; Koch, CA; Schlaffer, SM | 1 |
| Grillo, CA; Libertun, C; Nicola, AF; Pietranera, L; Piroli, GG; Rey-Roldán, EB | 1 |
| Barahona Constanzo, MJ; del Pozo Picó, C | 1 |
| Buckingham, JC; Christian, HC; Morris, JF; Solito, E; Tierney, T | 1 |
| Guivarc'h, D; Vernier, P; Vincent, JD | 1 |
| Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
| Bons, EG; Lamberts, SW; Uitterlinden, P; Verleun, T | 1 |
| Bons, EG; Lamberts, SW; Uitterlinden, P | 1 |
| Lamberts, SW; van Koetsveld, P; Verleun, T | 1 |
| Den, K; Ohtani, K; Sakamoto, H; Suzuki, H; Takagi, S; Takahashi, T; Watanabe, Y | 1 |
2 review(s) available for mifepristone and Pituitary Neoplasms
| Article | Year |
|---|---|
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.
Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Hormone Antagonists; Humans; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms | 2013 |
New prospects for drug treatment in Cushing disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin | 2012 |
1 trial(s) available for mifepristone and Pituitary Neoplasms
| Article | Year |
|---|---|
Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Corticotrophs; Female; Hormone Antagonists; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Middle Aged; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Prospective Studies; Receptors, Glucocorticoid | 2014 |
9 other study(ies) available for mifepristone and Pituitary Neoplasms
| Article | Year |
|---|---|
Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
Topics: Adrenocorticotropic Hormone; Corticotrophs; Hedgehog Proteins; Humans; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Receptors, Glucocorticoid | 2023 |
Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
Topics: Animals; Binding, Competitive; Carcinogens; Diethylstilbestrol; Hormone Antagonists; Levonorgestrel; Male; Mifepristone; Organ Size; Ovariectomy; Pituitary Gland, Anterior; Pituitary Neoplasms; Progesterone Congeners; Prolactin; Rats; Rats, Inbred F344; Receptors, Androgen; Receptors, Progesterone | 2008 |
Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release.
Topics: Adrenocorticotropic Hormone; Animals; Annexin A1; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Glucocorticoids; Hormone Antagonists; Mifepristone; Paracrine Communication; Pituitary Gland; Pituitary Neoplasms; RNA, Messenger | 2003 |
Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line.
Topics: Alternative Splicing; Animals; Base Sequence; Cells, Cultured; Estrogens; Female; Mifepristone; Molecular Sequence Data; Pituitary Neoplasms; Prolactin; Rats; Receptors, Androgen; Receptors, Dopamine D2; Receptors, Estrogen; Testosterone | 1998 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Body Weight; Cells, Cultured; Estrenes; Female; Megestrol; Megestrol Acetate; Mifepristone; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1985 |
Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Estrenes; Female; Humans; Mifepristone; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Steroid | 1985 |
Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Topics: Animals; Cells, Cultured; Dexamethasone; Estradiol; Estrenes; Megestrol; Megestrol Acetate; Mifepristone; Pituitary Neoplasms; Progesterone; Prolactin; Rats; Rats, Inbred BUF; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Tamoxifen | 1987 |
A study of anti-progestational compound RU38486 action on the estrogen-induced enlargement of the rat pituitary gland.
Topics: Adenoma; Animals; Estradiol; Estrenes; Female; Mifepristone; Organ Size; Ovariectomy; Pituitary Gland; Pituitary Neoplasms; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estradiol | 1987 |